tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

TSE:NRX Stock Latest News

NurExone’s ExoPTEN Shows Promise for Glaucoma Treatment
Company AnnouncementsNurExone’s ExoPTEN Shows Promise for Glaucoma Treatment
8d ago
Promising Preliminary Results in Optic Nerve Recovery Study of NurExone’s first product ExoPTEN for Glaucoma
PremiumPress Releases
Promising Preliminary Results in Optic Nerve Recovery Study of NurExone’s first product ExoPTEN for Glaucoma
8d ago
NurExone Unveils Website and Conference Spotlight
PremiumCompany Announcements
NurExone Unveils Website and Conference Spotlight
20d ago
Updates from NurExone: Growth Conference Presentation and Website Relaunch
PremiumPress Releases
Updates from NurExone: Growth Conference Presentation and Website Relaunch
20d ago
NurExone Targets Vision Loss with ExoPTEN Therapy
PremiumCompany Announcements
NurExone Targets Vision Loss with ExoPTEN Therapy
27d ago
NurExone’s ExoPTEN Being Studied as Glaucoma Treatment for US$3.4 Billion Market
PremiumPress ReleasesNurExone’s ExoPTEN Being Studied as Glaucoma Treatment for US$3.4 Billion Market
27d ago
NurExone Biologic Uplifted by Drug Development Expert
PremiumCompany Announcements
NurExone Biologic Uplifted by Drug Development Expert
1M ago
On Path to First-in-Human Study, NurExone Engages Prominent Expert in Biological Drug Development
PremiumPress Releases
On Path to First-in-Human Study, NurExone Engages Prominent Expert in Biological Drug Development
1M ago
NurExone Secures Japanese Patent for ExoPTEN
PremiumCompany Announcements
NurExone Secures Japanese Patent for ExoPTEN
1M ago
NurExone Announces Expansion of ExoPTEN Patent Coverage with Notice of Allowance for Japanese Patent Application
PremiumPress Releases
NurExone Announces Expansion of ExoPTEN Patent Coverage with Notice of Allowance for Japanese Patent Application
1M ago
NurExone Shareholders Back Key Resolutions
PremiumCompany Announcements
NurExone Shareholders Back Key Resolutions
2M ago
NurExone Announces Voting Results from 2024 Annual Meeting of Shareholders
PremiumPress Releases
NurExone Announces Voting Results from 2024 Annual Meeting of Shareholders
2M ago
NurExone Biologic Inc.: Momentum and Market Growth
PremiumCompany AnnouncementsNurExone Biologic Inc.: Momentum and Market Growth
2M ago
NurExone Reports First Quarter 2024 Financial Results and Provides Corporate Update, moving forward with FDA guidelines for the Human Trials
PremiumPress Releases
NurExone Reports First Quarter 2024 Financial Results and Provides Corporate Update, moving forward with FDA guidelines for the Human Trials
2M ago
NurExone Enlists Biopharma Expert for Growth
PremiumCompany Announcements
NurExone Enlists Biopharma Expert for Growth
2M ago
NurExone Welcomes Biopharma Exec Dr. Ram Petter to Drive Strategic Collaborations
PremiumPress Releases
NurExone Welcomes Biopharma Exec Dr. Ram Petter to Drive Strategic Collaborations
2M ago
NurExone Biologic Expands U.S. Market Presence
PremiumCompany Announcements
NurExone Biologic Expands U.S. Market Presence
3M ago
NurExone Biologic Inc. Announces Strategic Expansion to US Financial Markets with Approval of OTCQB Listing Application and DTC Eligibility
PremiumPress Releases
NurExone Biologic Inc. Announces Strategic Expansion to US Financial Markets with Approval of OTCQB Listing Application and DTC Eligibility
3M ago
NurExone Showcases Spinal Injury Treatment Breakthrough
PremiumCompany Announcements
NurExone Showcases Spinal Injury Treatment Breakthrough
3M ago
NurExone Presenting on Revolutionary Spinal Cord Injury Therapy at European Conference on Exosomes and Regenerative Medicine
PremiumPress ReleasesNurExone Presenting on Revolutionary Spinal Cord Injury Therapy at European Conference on Exosomes and Regenerative Medicine
3M ago
NurExone Gains FDA Orphan-Drug Designation
PremiumCompany Announcements
NurExone Gains FDA Orphan-Drug Designation
4M ago
NurExone Reports Fourth Quarter and Year Ended December 31, 2023 Financial Results and Provides Company Update
PremiumPress Releases
NurExone Reports Fourth Quarter and Year Ended December 31, 2023 Financial Results and Provides Company Update
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >